DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Möbus V, Wandt H, Frickhofen N. et al.
Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.
J Clin Oncol 2007;
25: 4187-4193
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.